Animals marketing

Milk. Imitation milks fall into three broad categories filled products based on skim milk, buttermilk, whey, or combinations of these synthetic milks based on soybean products and toned milk based on the combination of soy or groundnut (peanut) protein with animal milk. Few caseinate-based products have been marketed (1,22,23). Milk is the one area where nutrition is of primary concern, especially in the diets of the young. Substitute milks are being made for human and animal markets. In the latter area, the emphasis is for products to serve as milk replacers for calves. The composition of milk and filled-milk products based on skim milk can be found in Table 10. Table 15 gives the composition of a whey /huttermilk-solids-hased calf-milk replacer, which contains carboxymethyl cellulose (CMC) for proper viscosity of the product. 

I have already alluded to the static livestock populations. Over the past 5 years, there has been a significant increase in the value of the companion animal market - 8.6% annual increase. If choices have to be made, then focussing research on this sector would seem to be more profitable. 

Company s recombinant bovine somatotropin (BST) into the veterinary food animal market. BST, also known as bovine growth hormone, rbST, rbGH, sometribove, and Posilac , is a drug designed to increase milk production in dairy cows. 

Many of the same indoles in human medicine could have parallel application in animal health and, indeed, some are used in both arenas. Both livestock and domestic pets may benefit, if only indirectly, from the huge research efforts of the pharmaceutical industry to develop pharmaceutical products. This is fortunate for there are far fewer companies today devoted strictly to veterinary medicine and animal health. However, the registration of a dmg for human use does not automatically mean that it can be used in the animal market. The approval process for a new animal health dmg is similar to the one for human medicine and the two are distinct. 

In veterinary medicine, the development of vaccine/drug delivery systems is intended for the livestock and companion animal populations. Livestock animals are those that are raised for food or other products, or kept for use such as meat and dairy. These include not only sheep, cattle, swine, goats, and poultry but also hsh and any other animals that enter the food chain. Among the companion animals (or pets), dogs, cats, and horses comprise the largest part. Other animals such as birds, reptiles, and rabbits can also be considered as companion animals. However, these species represent only a small fraction in the companion animal market. 

Recirculating systems can make aquaculture feasible in locations where conditions would otherwise not be conducive to successful operations. Such systems can also be used to reduce transportation costs by making it possible to grow animals near markets. In areas where there are concerns about pollution or the use of exotic species, closed systems provide an alternative approach to more extensive types of operations. 

Most poultry production, and a growing percentage of swiae production, takes place ia iatensive, confinement operations. Much of the poultry production is carried out under a system of vertical iategration ia which a producer hatches the chicks, grows them ia the producer s faciUties or ia contract facihties, provides the feed, processes the animals, and markets the product. This system of vertically iategrated production is not as common ia the swiae iadustry. 

Various sources of lipid have been incorporated into ruminant diets to increase the energy density and provide the large amount of energy needed for slaughter animals to achieve market weight or for dairy cows to produce milk (see Milk and milkproducts). Fats also reduce the dustiness of feeds, increase the feedstuffs abiUty to pellet, and improve feed acceptabiUty. 

Economic Market. The spice trade is controlled by many direct elements and responds slowly to supply and demand fluctuations. Resupply depends on growth to plant maturity, which for certain items, such as black pepper or nutmeg, can be several years. The raw material is directly affected by climate, adverse weather conditions, and control of plant diseases and insect and animal pests. Limited agricultural scientific advances are appHed to the cultivation of the botanicals, and there are many grades of product and degrees of quahty caused by different growing or processing conditions, sometimes by unknown factors as well. 

The most popular natural antioxidants on the market are rosemary extracts and tocopherols. Natural antioxidants have several drawbacks which limit use. Tocopherols are not as effective ia vegetable fats and oils as they are ia animal fats. Herb extracts often impart undesirable colors or flavors ia the products where used. In addition, natural antioxidants cost considerably more than synthetic ones. Despite this, the pubHc s uncertainty of the safety of synthetic antioxidants continues to fuel the demand for natural ones (21). 

Saccharin. Sacchatin [81-07-2] C H NO S, which is approximately 300 times as sweet as sucrose ia coaceatratioas up to the equivaleat of a 10% sucrose solutioa, has beea used commercially as a nonnutritive sweeteaer siace before 1900, predomiaanfly ia carboaated soft drioks, tabletop sweeteaers, and dietetic foods marketed primarily to diabetics. In 1977, the FDA proposed a ban on sacchatin because of its association with bladder cancer ia laboratory animals. At the time, it was the only commercially available nonnutritive sweetener, and pubflc outcry led to a delay of the ban, which was officially withdrawn ia 1991. Instead, the FDA required that warning labels be placed on all foods that contained the iagredient. Although sacchatin is heat stable, the pubflc debate over its safety, as well as the fact that approximately one-third of the population perceives it to have a bitter aftertaste, has limited its use. 

The 1993 market for LPC-type products in the United States was for dried alfalfa meal for animal feed. This product is sold for both protein and carotenoid content. The USDA Pro-Xan product attempts to obtain improved xanthophyU contents for use in egg-laying rations in addition to protein contents. The limitations to commercial development of LPC products for human food use are high capital costs as compared with the low yields of protein, seasonal availabihty of raw materials, and the need in the United States for FDA approval of the products. 

In general, nonconventional protein foods must be competitive with conventional plant and animal protein sources on the bases of cost delivered to the consumer, nutritional value to humans or animals, functional value in foods, sensory quality, and social and cultural acceptability. Also, requirements of regulatory agencies in different countries for freedom from toxins or toxic residues in single-cell protein products, toxic glycosides in leaf protein products, pathogenic microorganisms, heavy metals and toxins in fish protein concentrates, or inhibitory or toxic peptide components in synthetic peptides must be met before new nonconventional food or feed protein products can be marketed. 

U.S.A., in lactating dairy cattie to increase milk production. EH Lilly and Company, The Upjohn Company, and American Cyanamid Company also have interests in the commercial appHcation of recombinant bovine GH. Recombinant porcine GH [9061-23-8] preparations from several companies, eg. The Upjohn Company, Smith Kline Beecham Animal Health, Pitman-Moore, Inc., Monsanto Company, and American Cyanamid Company, are being evaluated for commercial use. Recombinant human GH for clinical use is marketed under such names as Protropin (Genentech), Umatrope (EH Lilly), Genotropin (Sumitomo), and Somatonorm (Kabi-Vitmm) by a variety of pharmaceutical companies. A listing of additional suppHers is available (2). 

The sale of hides is on a weight basis. The value of a hide depends on the type of animal, the seasonal characteristics, the location of the slaughter, the type of cure, and the market conditions. Cost of the hides is about 50% of the sale price of the leather, so an accurate knowledge of the hides and the leathermaking potential of the hides is critical to commercial success. In the case of furs and exotic skin leather production, the value of the pelt is by far the most important factor (7). 

Mineral Feed. Mineral feed supplements for domestic animals and fowl usually contain a pure form of pulverized limestone. In fact, some state laws require the supplement to be at least 35% available calcium. Other sources of calcium are bone meal and dicalcium phosphate. Use as mineral feed has been a steadily growing market for limestone. The material is ground to 90% minus 0.15 mm (100 mesh) or 80% minus 0.9074 mm (200 mesh), is low in silica, and has strict tolerances on arsenic and fluorine (see Feeds and feed additives). 

Chemical fertiliser is the predominant market for langbeinite. Comparatively small but increasing amounts of langbeinite are used by the animal feed ingredient industry (see Feeds and feed additives). Producers who supply this market must take special precautions to be sure that any langbeinite intended as an animal feed ingredient meets all USDA specifications for toxic heavy metals and other impurities. 

Sevoflurane. Sevoflurane, l,l,l,3,3,3-hexafluoro-2-propyl fluromethyl ether [28523-86-6] is nonpungent, suggesting use in induction of anesthesia. The blood/gas partition coefficient is less than other marketed products (Table 1) yet similar to nitrous oxide, suggesting fast onset and recovery. In animal studies, recovery was faster for sevoflurane than for isoflurane, enflurane, or halothane (76). Sevoflurane is stable to light, oxygen, and metals (28). However, the agent does degrade in soda lime (77). 

Coccidiosis is a proto2oal disease of the intestinal tract of animals that leads to severe loss of productivity and death. The development and widespread use of anticoccidials has revolutionized the poultry industry. The estimated world market for anticoccidial agents in 1989 was 425 million and this was dominated by the polyether ionophore antibiotics monensin, salinomycin [53003-10-4], n imsm [55134-13-9], la.s9locid, and maduramicin [84878-61-5] (26). 

Animal Pharm, Feed Additives, The Market,Y O PubHcations Ltd, Richmond, Surrey, UK, 1987. 

---